Leptin restores plasma cholesterol, glucose and weight loss induced by IFNα treatment

Ruth Z. Birk, Menachem Rubinstein

    Research output: Contribution to journalArticlepeer-review

    3 Scopus citations


    Leptin, an adipokine, a major regulator of food intake, was recently suggested to play a role in immune response. We previously showed that weight reduction following IFNα therapy is due, at least in part, to direct induction of adipose tissue apoptosis. We now studied the effect of leptin on IFNα treated adipocytes in vitro and in vivo. Diet induced obese C57/B6 mice were treated continually with recombinant (r) IFNαA/D + leptin (100 U/g body weight + 10 μg/day, respectably) or leptin (10 μg/day) alone for 8 days. Co-administration of IFNαA/D + leptin significantly reduced plasma cholesterol (P < 0.001), glucose (P < 0.007) and pro-apoptotic protein levels (P < 0.05). Additionally, co-administration prevented loss of body weight due to adipocyte apoptosis. Thus, leptin co-administration with IFNαA/D decreases some of the side effects of IFNα administration such as weight loss, cholesterol and glucose levels.

    Original languageEnglish
    Pages (from-to)626-631
    Number of pages6
    JournalBiochemical and Biophysical Research Communications
    Issue number3
    StatePublished - 13 Apr 2007


    • Adipocytes
    • Body weight
    • Diet-induce obesity
    • IFNα
    • Leptin

    ASJC Scopus subject areas

    • Biophysics
    • Biochemistry
    • Molecular Biology
    • Cell Biology


    Dive into the research topics of 'Leptin restores plasma cholesterol, glucose and weight loss induced by IFNα treatment'. Together they form a unique fingerprint.

    Cite this